-
Mashup Score: 4First Site Activated In EU-Funded DE-ESCALATE Clinical Trial On Advance Metastatic Prostate Cancer - 4 day(s) ago
We are delighted to announce the official start of DE-ESCALATE, a pragmatic Phase III clinical trial focusing on metastatic prostate cancer.
Source: www.eortc.orgCategories: General Medicine NewsTweet
-
Mashup Score: 9First Site Activated In EU-Funded DE-ESCALATE Clinical Trial On Advance Metastatic Prostate Cancer - 5 day(s) ago
We are delighted to announce the official start of DE-ESCALATE, a pragmatic Phase III clinical trial focusing on metastatic prostate cancer.
Source: www.eortc.orgCategories: General Medicine NewsTweet-
We are delighted to announce the official start of the @HorizonEU funded @DeEscalate_EU #ClinicalTrial on metastatic #prostatecancer, in collaboration with Syreon Research Institute. More: https://t.co/FhE4wcOPM9 @EU_Commission #DEESCALATE_Horizon #HorizonEurope #MensHealthWeek https://t.co/rZXIHnyY5K
-
-
Mashup Score: 8EORTC Publishes Its 2024 Annual Report: Driving Progress In Cancer Treatment, Together - EORTC - 10 day(s) ago
The European Organisation for Research and Treatment of Cancer (EORTC) announces the publication of its 2024 Annual Report, available online.
Source: www.eortc.orgCategories: General Medicine NewsTweet-
📢 Just released: the EORTC 2024 Annual Report is now online! From groundbreaking clinical trials to expanded global partnerships, see how we are driving progress in cancer treatment, together. 🔗 https://t.co/YdTNlTAD34 #Oncology #CancerResearch #ClinicalTrials https://t.co/3zOHjpKOqj
-
-
Mashup Score: 3EORTC In The Spotlight At ASCO 2025 - 11 day(s) ago
8 EORTC studies were accepted at ASCO 2025 in Chicago, 3 for oral presentation and 5 as posters.
Source: www.eortc.orgCategories: General Medicine News, Onc News and JournalsTweet-
What an incredible experience to take part in this year’s ASCO Congress! Congratulations to all the EORTC members who represented us at this prestigious event.👨‍⚕️ Learn more about the EORTC abstracts presented at #ASCO25: https://t.co/Hi9hVV0g8M @ASCO #CancerResearch #Oncology https://t.co/Vykwp2vPZD
-
-
Mashup Score: 12EORTC Will Participate In The ASCO 2025 Congress - 12 day(s) ago
EORTC will participate in the ASCO 2025 Annual Meeting with eight abstracts, including three oral presentations and five poster sessions.
Source: www.eortc.orgCategories: General Medicine NewsTweet-
🎉Excited to join #ASCO25 in Chicago! EORTC will present 8 abstracts, 3 oral sessions and 5 posters, sharing breakthroughs in brain, breast, lung, head & neck, melanoma, and genitourinary cancers. Find out more: https://t.co/7i6B5wWFCi @ASCO #Oncology #ClinicalTrials https://t.co/YW0Noo949E
-
-
Mashup Score: 12EORTC Will Participate In The ASCO 2025 Congress - 14 day(s) ago
EORTC will participate in the ASCO 2025 Annual Meeting with eight abstracts, including three oral presentations and five poster sessions.
Source: www.eortc.orgCategories: General Medicine NewsTweet-
🎉Excited to join #ASCO25 in Chicago! EORTC will present 8 abstracts, 3 oral sessions and 5 posters, sharing breakthroughs in brain, breast, lung, head & neck, melanoma, and genitourinary cancers. Find out more: https://t.co/7i6B5wWFCi @ASCO #Oncology #ClinicalTrials https://t.co/YW0Noo949E
-
-
Mashup Score: 12EORTC Will Participate In The ASCO 2025 Congress - 16 day(s) ago
EORTC will participate in the ASCO 2025 Annual Meeting with eight abstracts, including three oral presentations and five poster sessions.
Source: www.eortc.orgCategories: General Medicine NewsTweet-
🎉Excited to join #ASCO25 in Chicago! EORTC will present 8 abstracts, 3 oral sessions and 5 posters, sharing breakthroughs in brain, breast, lung, head & neck, melanoma, and genitourinary cancers. Find out more: https://t.co/7i6B5wWFCi @ASCO #Oncology #ClinicalTrials https://t.co/YW0Noo949E
-
-
Mashup Score: 1The 500th patient was enrolled in the ReCare cohort - 16 day(s) ago
We are pleased to announce that the ReCare cohort of the E²-RADIatE platform successfully enrolled its 500th patient.
Source: project.eortc.orgCategories: General Medicine NewsTweet-
🎉We’re proud to share that the RP-2011 #ReCare cohort of the #E2RADIatE platform reached a major milestone: its 500th patient enrolled since launching in May 2023. This marks the successful completion of the first phase of recruitment. Learn more: https://t.co/Jg1U3J6E7W https://t.co/4YJB341F41
-
-
Mashup Score: 12EORTC Will Participate In The ASCO 2025 Congress - 18 day(s) ago
EORTC will participate in the ASCO 2025 Annual Meeting with eight abstracts, including three oral presentations and five poster sessions.
Source: www.eortc.orgCategories: General Medicine NewsTweet-
🎉Excited to join #ASCO25 in Chicago! EORTC will present 8 abstracts, 3 oral sessions and 5 posters, sharing breakthroughs in brain, breast, lung, head & neck, melanoma, and genitourinary cancers. Find out more: https://t.co/7i6B5wWFCi @ASCO #Oncology #ClinicalTrials https://t.co/YW0Noo949E
-
-
Mashup Score: 5Clinical Trial Statistics For Non-Statisticians 25 - EORTC - 19 day(s) ago
W3BhZ2UtdGFic11bL3BhZ2UtdGFic10g
Source: www.eortc.orgCategories: General Medicine NewsTweet-
📢 Registrations for the EORTC course Clinical Trial Statistics for Non-Statisticians are open! 📅 Date: 10-13 June 2025 👉 Visit https://t.co/QhFYXoGBnj #STATS2025 #CancerResearch #ClinicalTrials #StatisticalMethods #ClinicalResearch https://t.co/elcf7w53wd
-
We are delighted to announce the official start of the @HorizonEU funded @DeEscalate_EU #ClinicalTrial on metastatic #prostatecancer, in collaboration with Syreon Research Institute. More: https://t.co/fomlh0wovI @EU_Commission #DEESCALATE_Horizon #HorizonEurope #MensHealthWeek https://t.co/S8igjoYAlV